1716P Do proton pump inhibitors affect the survival outcomes and safety in colorectal cancer patients treated with regorafenib? A single center and real-life experience

Autor: Yekeduz, E., Özyurt, N., Köksoy, E.B., Akbıyık, I., Kalacı, E., Ürün, Y., Utkan, G.
Zdroj: In Annals of Oncology September 2021 32 Supplement 5:S1192-S1192
Databáze: ScienceDirect